Literature DB >> 17090567

Comparison of a TaqMan-based real-time polymerase chain reaction with conventional tests for the detection of Trichomonas vaginalis.

A Pillay1, F Radebe, G Fehler, Y Htun, R C Ballard.   

Abstract

OBJECTIVE: To compare a TaqMan-based real-time polymerase chain reaction (PCR) with conventional PCR, culture, and wet-mount microscopy for the diagnosis of trichomoniasis in women.
METHODS: Vaginal swabs from 119 women were tested for Trichomonas vaginalis by wet mount and culture. Paired vaginal lavage and urine specimens were tested by conventional and real-time PCR.
RESULTS: Using an expanded "gold standard", defined as a positive culture result using vaginal swabs and/or a positive PCR test using TVK3/7 primers, the overall prevalence of T vaginalis in the study population was 65.5% (78/119). The detection rate of T vaginalis was 65.5% (78/119) and 36.9% (44/119) by conventional PCR using vaginal washings and urine specimens, respectively; 68.9% (82/119) by real-time PCR using vaginal washings and 61.3% (73/119) by real-time PCR using urine specimens. The sensitivities of conventional PCR using vaginal washings and urine and real-time PCR using vaginal washings and urine, compared with the gold standard were 100%, 56.4%, 100% and 76.7%, and the specificities of these tests were 100%, 97.6%, 82.9% and 97%, respectively.
CONCLUSIONS: The real-time PCR test proved to be significantly more sensitive than culture and wet-mount microscopy, although its specificity was slightly lower than these tests. In addition, it was more sensitive, rapid and less time consuming than conventional PCR for the detection of T vaginalis.

Entities:  

Mesh:

Year:  2006        PMID: 17090567      PMCID: PMC2598620          DOI: 10.1136/sti.2006.022376

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  18 in total

Review 1.  Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel.

Authors:  W Cates
Journal:  Sex Transm Dis       Date:  1999-04       Impact factor: 2.830

2.  Comparison of conventional testing to polymerase chain reaction in detection of Trichomonas vaginalis in indigenous women living in remote areas.

Authors:  K S Smith; S N Tabrizi; K A Fethers; J B Knox; C Pearce; S M Garland
Journal:  Int J STD AIDS       Date:  2005-12       Impact factor: 1.359

3.  Evaluation of use of a single intravaginal swab to detect multiple sexually transmitted infections in active-duty military women.

Authors:  A M Rompalo; C A Gaydos; N Shah; M Tennant; K A Crotchfelt; G Madico; T C Quinn; R Daniel; K V Shah; J C Gaydos; K T McKee
Journal:  Clin Infect Dis       Date:  2001-09-24       Impact factor: 9.079

4.  Vaginal swabs versus lavage for detection of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women.

Authors:  Patricia J Kissinger; Jeanne Dumestre; Rebecca A Clark; Luann Wenthold; Hamish Mohammed; Michael E Hagensee; David H Martin
Journal:  Sex Transm Dis       Date:  2005-04       Impact factor: 2.830

5.  Bacterial vaginosis and lower genital tract infections in women attending out-patient clinics at a tertiary institution serving a developing community.

Authors:  A B Kharsany; A A Hoosen; J Moodley
Journal:  J Obstet Gynaecol       Date:  1997-03       Impact factor: 1.246

6.  Trichomonas vaginalis polymerase chain reaction compared with standard diagnostic and therapeutic protocols for detection and treatment of vaginal trichomoniasis.

Authors:  Karen A Wendel; Emily J Erbelding; Charlotte A Gaydos; Anne M Rompalo
Journal:  Clin Infect Dis       Date:  2002-08-06       Impact factor: 9.079

7.  Evaluation of Xenostrip-Tv, a rapid diagnostic test for Trichomonas vaginalis infection.

Authors:  A Pillay; J Lewis; R C Ballard
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

8.  Comparison of culture and different PCR assays for detection of Trichomonas vaginalis in self collected vaginal swab specimens.

Authors:  T Crucitti; E Van Dyck; A Tehe; S Abdellati; B Vuylsteke; A Buve; M Laga
Journal:  Sex Transm Infect       Date:  2003-10       Impact factor: 3.519

9.  Trichomonas vaginalis: repeated DNA target for highly sensitive and specific polymerase chain reaction diagnosis.

Authors:  P Kengne; F Veas; N Vidal; J L Rey; G Cuny
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  1994-09       Impact factor: 1.770

10.  Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs.

Authors:  A M Caliendo; J A Jordan; A M Green; J Ingersoll; R J Diclemente; G M Wingood
Journal:  Infect Dis Obstet Gynecol       Date:  2005-09
View more
  11 in total

1.  Ureaplasma parvum and Ureaplasma urealyticum detected with the same frequency among women with and without symptoms of urogenital tract infection.

Authors:  M Marovt; D Keše; T Kotar; N Kmet; J Miljković; B Šoba; M Matičič
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-02-26       Impact factor: 3.267

2.  Antimicrobial Resistance of Neisseria gonorrhoeae Isolates from High-Risk Men in Johannesburg, South Africa.

Authors:  Liteboho D Maduna; Marleen M Kock; Brian M J W van der Veer; Oscar Radebe; James McIntyre; Lieke B van Alphen; Remco P H Peters
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

3.  Rare case of trichomonal peritonitis.

Authors:  Crystal A Zalonis; Allan Pillay; William Secor; Burth Humburg; Robert Aber
Journal:  Emerg Infect Dis       Date:  2011-07       Impact factor: 6.883

4.  Detecting the Diversity of Mycoplasma and Ureaplasma Endosymbionts Hosted by Trichomonas vaginalis Isolates.

Authors:  Anastasios Ioannidis; Panagiota Papaioannou; Emmanouil Magiorkinis; Maria Magana; Vasiliki Ioannidou; Konstantina Tzanetou; Angeliki R Burriel; Maria Tsironi; Stylianos Chatzipanagiotou
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640

5.  Male circumcision and Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis: observations after a randomised controlled trial for HIV prevention.

Authors:  J Sobngwi-Tambekou; D Taljaard; M Nieuwoudt; P Lissouba; A Puren; B Auvert
Journal:  Sex Transm Infect       Date:  2008-12-15       Impact factor: 3.519

6.  Cervical ectopy: associations with sexually transmitted infections and HIV. A cross-sectional study of high school students in rural South Africa.

Authors:  Elisabeth Kleppa; Sigve D Holmen; Kristine Lillebø; Eyrun F Kjetland; Svein Gunnar Gundersen; Myra Taylor; Prashini Moodley; Mathias Onsrud
Journal:  Sex Transm Infect       Date:  2014-10-03       Impact factor: 3.519

7.  Trichomonas vaginalis infection is uncommon in the British general population: implications for clinical testing and public health screening.

Authors:  Nigel Field; Soazig Clifton; Sarah Alexander; Catherine A Ison; Rumena Khanom; Pamela Saunders; Gwenda Hughes; Laura Heath; Simon Beddows; Catherine H Mercer; Clare Tanton; Anne M Johnson; Pam Sonnenberg
Journal:  Sex Transm Infect       Date:  2016-09-29       Impact factor: 3.519

Review 8.  A New Gold Rush: A Review of Current and Developing Diagnostic Tools for Urinary Tract Infections.

Authors:  Raymond Xu; Nicholas Deebel; Randy Casals; Rahul Dutta; Majid Mirzazadeh
Journal:  Diagnostics (Basel)       Date:  2021-03-09

9.  Single gene targeted nanopore sequencing enables simultaneous identification and antimicrobial resistance detection of sexually transmitted infections.

Authors:  Liqing Zhou; Andrea Lopez Rodas; Luz Marina Llangarí; Natalia Romero Sandoval; Philip Cooper; Syed Tariq Sadiq
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

10.  High prevalence of antibiotic-resistant Mycoplasma genitalium in nongonococcal urethritis: the need for routine testing and the inadequacy of current treatment options.

Authors:  Marcus J Pond; Achyuta V Nori; Adam A Witney; Rose C Lopeman; Philip D Butcher; Syed Tariq Sadiq
Journal:  Clin Infect Dis       Date:  2013-11-26       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.